Sera from Remitting and Secondary Progressive Multiple Sclerosis Patients Disrupt the Blood-Brain Barrier-Reference-Cited by-同舟云学术

Sera from Remitting and Secondary Progressive Multiple Sclerosis Patients Disrupt the Blood-Brain Barrier

Published:2014-03-31 Issue:3 Volume:9 Page:e92872
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Shimizu Fumitaka,Tasaki Ayako,Sano Yasuteru,Ju Mihua,Nishihara Hideaki,Oishi Mariko,Koga Michiaki,Kawai Motoharu,Kanda Takashi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343: , 938–52.

2. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46: , 907–11.

3. Cotton F, Weiner HL, Jolesz FA, Guttmann CR (2003) MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology 60: , 640–6.

4. Coles AJ, Wing MG, Molyneux P, Paolillo A, Davie CM, et al.. (1999) Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol 46: , 296–304.

5. Anderson VM, Fox NC, Miller DH (2006) Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. J Magn Reson Imaging 23: , 605–18.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma IgG aggregates as biomarkers for multiple sclerosis;Clinical Immunology;2023-11

2. Multiple sclerosis plasma IgG aggregates induce complement-dependent neuronal apoptosis;Cell Death & Disease;2023-04-08

3. Higher Levels of IgG3 Antibodies in Serum, But Not in CSF, Distinguish Multiple Sclerosis From Other Neurological Disorders;Journal of Neuroimmune Pharmacology;2022-01-06

4. GRP78 Antibodies Are Associated With Blood-Brain Barrier Breakdown in Anti–Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disorder;Neurology - Neuroimmunology Neuroinflammation;2021-11-01

5. Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction;Frontiers in Cellular Neuroscience;2021-09-13